Indeed, some gynecological cancers, e.g. cervical cancer, are characterized by relatively low percentages of TP53-mutant cases [17], and in several types of gynecological cancers, e.g breast and ovarian cancer, TP53 mutations are known to confer a poor prognosis [22, 26, 27]. The gene discussed is TP53; the disease is female reproductive organ cancer.